![Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a4eb7df3-c49d-42a7-ab98-80ea9b2ef173/gr1_lrg.jpg)
Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine
![Safety of Long-Acting Beta-Agonists in the Treatment of Asthma: Should they be used? – Clinical Correlations Safety of Long-Acting Beta-Agonists in the Treatment of Asthma: Should they be used? – Clinical Correlations](https://www.clinicalcorrelations.org/wp-content/uploads/2007/02/509px-asthmainhaler.jpg)
Safety of Long-Acting Beta-Agonists in the Treatment of Asthma: Should they be used? – Clinical Correlations
Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia | PLOS ONE
![Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/28bdc4a8-32bf-4c5c-ac34-c19770c1cb5e/dta2728-fig-0001-m.jpg)
Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges - Hostrup - 2020 - Drug Testing and Analysis - Wiley Online Library
![PDF] Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. | Semantic Scholar PDF] Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/beec0f5be7b7c5853207078d6c52125ceff1cef5/3-Table1-1.png)
PDF] Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. | Semantic Scholar
![PDF] Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD? | Semantic Scholar PDF] Do long-acting beta2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92b46301ce2fb548ac907cbd29bbb88363b804a4/2-Figure2-1.png)